Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
15,020 results in PubMed
Peer-reviewed biomedical literature from the US National Library of Medicine, most relevant first. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- The efficacy of music therapy to relieve pain, anxiety, and promote sleep quality, in patients with small cell lung cancer receiving platinum-based chemotherapy.
Tang H, Chen L, Wang Y, et al. · Support Care Cancer · 2021Randomized Controlled Trial
- Comprehensive Analysis of Lung Cancer Metastasis: Sites, Rates, Survival, and Risk Factors-A Systematic Review and Meta-Analysis.
Wang S, Tang W, Jin F, et al. · Clin Respir J · 2025Systematic Review, Meta-Analysis
- First-line serplulimab plus chemotherapy in extensive-stage small-cell lung cancer: Updated results and biomarker analysis from the ASTRUM-005 randomized clinical trial.
Cheng Y, Zhang S, Han L, et al. · Cancer Commun (Lond) · 2025Randomized Controlled Trial, Clinical Trial, Phase III
- Ifinatamab Deruxtecan in Patients With Extensive-Stage Small Cell Lung Cancer: Primary Analysis of the Phase II IDeate-Lung01 Trial.
Rudin CM, Johnson ML, Paz-Ares L, et al. · J Clin Oncol · 2026Clinical Trial, Phase II, Randomized Controlled Trial
- Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study.
Reck M, Dziadziuszko R, Sugawara S, et al. · Lung Cancer · 2024Clinical Trial, Phase III, Randomized Controlled Trial
- Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial.
Chang JY, Lin SH, Dong W, et al. · Lancet · 2023Randomized Controlled Trial, Clinical Trial, Phase II
- Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer.
Wang H, Yao Z, Kang K, et al. · Med · 2024Clinical Trial, Phase II, Multicenter Study
- Lung cancer.
Neville AJ, Kuruvilla MS · BMJ Clin Evid · 2010Systematic Review
- High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial.
Yu J, Jiang L, Zhao L, et al. · Lancet Respir Med · 2024Clinical Trial, Phase III, Randomized Controlled Trial
- Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.
Rodríguez de Dios N, Couñago F, Murcia-Mejía M, et al. · J Clin Oncol · 2021Clinical Trial, Phase III, Multicenter Study
- Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.
Faivre-Finn C, Snee M, Ashcroft L, et al. · Lancet Oncol · 2017Clinical Trial, Phase III, Multicenter Study
- Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.
J Thorac Oncol · 2019Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005.
Higgins KA, Hu C, Ross HJ, et al. · J Clin Oncol · 2026Clinical Trial, Phase III, Randomized Controlled Trial
- Plain language summary: tarlatamab for patients with previously treated small cell lung cancer.
Ahn MJ, Cho BC, Felip E, et al. · Future Oncol · 2024Clinical Trial, Phase III, Multicenter Study
- NOTCH1 reverses immune suppression in small cell lung cancer through reactivation of STING.
Kim YS, Nabet BY, Cortez BN, et al. · J Clin Invest · 2025Clinical Trial, Research Support, Non-U.S. Gov't
- Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial.
Weiss JM, Csoszi T, Maglakelidze M, et al. · Ann Oncol · 2019Clinical Trial, Phase I, Clinical Trial, Phase II
- Asbestos exposure and small cell lung cancer: Systematic review and meta-analysis.
Curiel-García T, Rey-Brandariz J, Varela-Lema L, et al. · J Occup Environ Hyg · 2023Meta-Analysis, Systematic Review
- Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies.
Nuccio A, Viscardi G, Salomone F, et al. · Eur J Cancer · 2023Meta-Analysis, Systematic Review
- Lung cancer.
Neville A · BMJ Clin Evid · 2009Systematic Review
- Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study.
Xie M, Vuko M, Rodriguez-Canales J, et al. · Mol Cancer · 2024Clinical Trial, Phase III, Randomized Controlled Trial
- Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial.
Takahashi T, Yamanaka T, Seto T, et al. · Lancet Oncol · 2017Clinical Trial, Phase III, Comparative Study
- Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial.
Baize N, Monnet I, Greillier L, et al. · Lancet Oncol · 2020Clinical Trial, Phase III, Randomized Controlled Trial
- Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study.
Xie M, Bao M, Dong X, et al. · Signal Transduct Target Ther · 2025Clinical Trial, Phase II, Research Support, Non-U.S. Gov't
- Comparative efficacy of tarlatamab and second-line therapies in extensive-stage small cell lung cancer: A network meta-analysis.
Wang J, Takundwa R, Yang H, et al. · Lung Cancer · 2026Network Meta-Analysis, Comparative Study
- Residential radon and small cell lung cancer. A systematic review.
Rodríguez-Martínez Á, Torres-Durán M, Barros-Dios JM, et al. · Cancer Lett · 2018Comparative Study, Research Support, Non-U.S. Gov't
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.